Septerna (SEPN) Change in Accured Expenses (2023 - 2026)

Septerna's quarterly Change in Accured Expenses came in at -$3.5 million in Q1 2026, down 2.52% year-on-year from -$3.6 million in Q1 2025, and down 181.42% quarter-over-quarter from $4.3 million in Q4 2025.

Septerna has reported Change in Accured Expenses for 4 years, with the latest figure at -$3.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 2.52% year-over-year to -$3.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 146.22% YoY), and the FY2025 full-year result was $4.4 million, up 22.31% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$3.5 million, down from $4.3 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $4.3 million in Q4 2025, with the low at -$3.5 million in Q1 2026.
  • Average Change in Accured Expenses over 4 years is $630200.0, with a median of $1.6 million recorded in 2023.
  • Peak annual rise in Change in Accured Expenses reached 795.8% in 2025, while the deepest fall reached 113.11% in 2025.
  • Tracing SEPN's Change in Accured Expenses over 4 years: stood at $1.9 million in 2023, then jumped by 56.12% to $3.0 million in 2024, then jumped by 45.36% to $4.3 million in 2025, then tumbled by 181.42% to -$3.5 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$3.5 million (Q1 2026), $4.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 Septerna 1.34 Bn 1.34 Bn - -3.53 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.53 Mn
Mar 31, 2026 -3.53 Mn
Dec 31, 2025 4.34 Mn
Dec 31, 2025 4.34 Mn
Sep 30, 2025 1.28 Mn
Sep 30, 2025 1.28 Mn
Jun 30, 2025 2.19 Mn
Jun 30, 2025 2.19 Mn
Mar 31, 2025 -3.45 Mn
Mar 31, 2025 -3.45 Mn
Dec 31, 2024 2.99 Mn
Dec 31, 2024 2.99 Mn
Sep 30, 2024 143,000.00
Sep 30, 2024 143,000.00
Jun 30, 2024 2.05 Mn
Jun 30, 2024 2.05 Mn
Mar 31, 2024 -1.62 Mn
Mar 31, 2024 -1.62 Mn
Dec 31, 2023 1.91 Mn
Dec 31, 2023 1.91 Mn